INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "GASTROINTESTINAL CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS"

GENEVA, Oct. 15 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/023365) for "GASTROINTESTINAL CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS" on Apr 07, 2025. With publication no. WO/2025/213154, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BELMONTES, Brian (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), SLEMMONS, Katherine (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), EGGERT...